- Author:
Nouran A ALEYEIDI
1
;
Khaled S ASERI
2
;
Shadia M MATBOULI
3
;
Albaraa A SULAIAMANI
4
;
Sumayyah A KOBEISY
5
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Blood Pressure; Complementary Therapies; adverse effects; Female; Humans; Hypertension; therapy; Male; Middle Aged
- From: Journal of Integrative Medicine 2015;13(6):391-399
- CountryChina
- Language:English
-
Abstract:
BACKGROUNDAlthough cupping remains a popular treatment modality worldwide, its efficacy for most diseases, including hypertension, has not been scientifically evaluated.
OBJECTIVEWe aimed to determine the efficacy of wet-cupping for high blood pressure, and the incidence of the procedure's side effects in the intervention group.
DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONSThis is a randomized controlled trial conducted in the General Practice Department at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between May 2013 and February 2014. There were two groups (40 participants each): intervention group undergoing wet-cupping (hijama) in addition to conventional hypertension treatment, and a control group undergoing only conventional hypertension treatment. Three wet-cupping sessions were performed every other day.
MAIN OUTCOME MEASUREThe mean systolic and diastolic blood pressures were measured using a validated automatic sphygmomanometer. The follow-up period was 8 weeks.
RESULTSWet-cupping provided an immediate reduction of systolic blood pressure. After 4 weeks of follow-up, the mean systolic blood pressure in the intervention group was 8.4 mmHg less than in the control group (P=0.046). After 8 weeks, there were no significant differences in blood pressures between the intervention and control groups. In this study, wet-cupping did not result in any serious side effects.
CONCLUSIONWet-cupping therapy is effective for reducing systolic blood pressure in hypertensive patients for up to 4 weeks, without serious side effects. Wet-cupping should be considered as a complementary hypertension treatment, and further studies are needed.
TRIAL REGISTRATIONClinicalTrials.gov Identifier NCT01987583.